USA Rare Earth
USAR
$12.56
-0.55%
USA Rare Earth, Inc. is a vertically integrated domestic rare earth magnet supply chain company developing an NdFeB magnet manufacturing plant in the United States while establishing rare earth and critical minerals extraction and processing capabilities to supply both its own plant and third-party customers, operating in the Basic Materials sector within Industrial Materials. The company is a pre-revenue, early-stage strategic player rather than a scaled producer, positioning itself as a national-security-adjacent platform intended to break China's dominance in rare earth magnets, with only 132 employees and a single reportable operating segment. The current investor narrative is dominated by a transformative government-backed funding and purchase-contract deal, the pending acquisition of Serra Verde, and groundbreaking on a $1.2 billion South Carolina facility, all of which have driven sharp sentiment swings. This bullish narrative is heavily counterbalanced by massive shareholder dilution, a $3.5 billion capital raise, China export restrictions, a legal dispute with MP Materials, and a stock that has fallen dramatically from its highs, making USAR a high-risk, high-conviction policy-driven speculation.…
USAR
USA Rare Earth
$12.56
Related headlines
Investment Opinion: Should I buy USAR Today?
The synthesized recommendation is Hold, with a speculative bias. The core thesis is that USAR offers genuine strategic optionality as a domestic rare earth magnet play backed by government contracts and a $1.594 billion cash pile, but the current fundamentals—negative gross margin of -69.82%, -$245.5 million TTM free cash flow, and a 709.95x PS ratio—do not yet justify a Buy. The analyst consensus of strong_buy with an average target of $35.56 implies 183% upside, but the stock trades 64% below even the lowest analyst target of $21.00, signaling a significant disconnect that could resolve either way.
Supporting evidence for the Hold rating includes the fortress balance sheet (current ratio 10.17, debt-to-equity 0.0062, $1.594 billion cash), the revenue inflection from zero in early 2025 to $5.821 million in Q2 2026, and the government-backed purchase contract that could transform the business. However, the negative gross margin of -69.82% and net margin of -181.11% show the company is far from profitable, and the forward PE of 418.67x on estimated EPS of $2.145 prices in a transformation that has not yet begun to appear in reported results. The 8.8x increase in shares outstanding since Q4 2024 is a massive overhang that dilutes any future per-share gains.
The biggest risks that could invalidate the thesis are execution delays on the $1.2 billion South Carolina facility, failure to close the Serra Verde acquisition on favorable terms, and continued negative gross margins requiring another dilutive raise. This Hold would upgrade to Buy if gross margins inflect above 0% and the company demonstrates positive operating cash flow, or if the stock breaks above the September swing high near $17.00 on volume. It would downgrade to Sell if the stock breaks below the 52-week low of $11.45 or if Q3 2026 gross margin fails to improve from -69.82%. Relative to its own history, the PB ratio of 2.37x is below the Q4 2025 level of 3.58x and well below 2024 levels above 8x, indicating significant de-rating, but the PS ratio of 709.95x remains near the high end of its historical band, so the stock is not cheap on a sales basis despite the price collapse.
Sign up to view all
USAR 12-Month Price Forecast
USAR presents a binary, policy-driven speculation where the bull case depends entirely on execution of government-backed contracts and the Serra Verde acquisition, while the bear case is anchored in a -69.82% gross margin and -$245.5 million TTM free cash flow. The $1.594 billion cash pile and 10.17 current ratio provide a multi-year runway, but the 8.8x share count increase since Q4 2024 means any future equity value must be divided among vastly more shares. The stock's 2.684 beta and -75.58% relative strength versus SPY over one year make it unsuitable for most portfolios, and the 183% upside to the $35.56 average target is offset by the risk of a break below $11.45. I would upgrade to bullish if Q3 2026 gross margin inflects above -30% and the Serra Verde deal closes, and downgrade to bearish if the stock breaks below $11.45 or if another large equity raise is announced.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on USA Rare Earth's 12-month outlook, with a consensus price target around $35.56 and implied upside of +183.1% versus the current price.
Average Target
$35.56
0 analysts
Implied Upside
+183.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$21 - $45
Analyst target range
USA Rare Earth is covered by 9 analysts, with a consensus recommendation of "strong_buy" and a recommendation mean of 1.11 (where 1.0 is a strong buy), indicating near-unanimous bullish sentiment. The average target price is $35.56, which implies massive upside of approximately 183% from the current price of $12.56, a spread that is unusually wide and reflects the binary nature of the investment case. The consensus leans overwhelmingly bullish, but the gap between the current price and the average target is so large that it suggests either the market is severely mispricing the stock or the analyst targets are stale and have not been updated to reflect the recent collapse in the share price. Given the stock is down 59.58% over the past year and 26.38% over the past month, the analyst community appears to be maintaining optimistic long-term views even as the market aggressively discounts the equity. The target range spans from a low of $21.00 to a high of $45.00, a spread of $24.00, or roughly 191% of the current price, which signals very high uncertainty and low conviction in any single price outcome. The high target of $45.00 assumes successful execution on the $1.2 billion South Carolina facility, closing of the Serra Verde acquisition, full government-backed revenue guarantees, and a successful ramp to profitability, essentially pricing in a best-case scenario. The low target of $21.00, while still 67% above the current price, likely prices in significant dilution, execution delays, margin compression, and competitive pressures from China and MP Materials. Institutional ratings show a pattern of reiterations rather than upgrades, with Needham, Roth Capital, Wedbush, Cantor Fitzgerald, and Canaccord Genuity all maintaining Buy or Outperform ratings through 2026, but no recent upgrades, suggesting analysts are holding steady rather than becoming more constructive. The wide target spread and the fact that the stock trades far below even the lowest target indicate a significant disconnect between analyst expectations and market pricing, which could resolve either through a sharp rally if execution improves or through analyst downgrades if fundamentals continue to deteriorate.
Bulls vs Bears: USAR Investment Factors
The bear case currently has stronger evidence: USAR trades at $12.56, just 9.7% above its 52-week low, with a -69.82% gross margin, -$245.5 million TTM free cash flow, and a 709.95x PS ratio that assumes a transformation not yet visible in results. The bull case rests almost entirely on future execution—government-backed contracts, the Serra Verde acquisition, and the $1.2 billion South Carolina facility—none of which have yet produced positive gross margins. The single most important tension is whether the government-backed revenue guarantees and Serra Verde integration can convert USAR from a cash-burning pre-revenue story into a cash-flow-positive producer before the $1.594 billion cash pile is depleted. If that conversion happens, the 183% upside to the $35.56 average analyst target is plausible; if it stalls, the stock risks a fresh breakdown below $11.45 with no fundamental floor.
Bullish
- Analyst consensus strong buy with 183% upside: All 9 covering analysts rate USAR a strong buy (recommendation mean 1.11), with an average target price of $35.56 versus the current $12.56, implying roughly 183% upside. Even the lowest target of $21.00 sits 67% above the current price, suggesting the market may be mispricing the equity relative to analyst expectations.
- Fortress balance sheet with $1.59B cash: USAR holds $1.594 billion in cash with a current ratio of 10.17 and a debt-to-equity ratio of just 0.0062, giving it substantial runway to fund the $1.2 billion South Carolina facility. This liquidity materially reduces near-term solvency risk despite deeply negative free cash flow of -$245.5 million TTM.
- Government-backed deal de-risks revenue: The transformative government-backed funding and purchase-contract deal, plus the Pentagon's $725 million bet on domestic critical minerals, provides revenue guarantees that could transform USAR from cash-burning to cash-flow positive. The pending Serra Verde acquisition would vertically integrate the mine-to-magnet supply chain.
- China export ban validates strategic value: China's export restrictions on US rare earth companies paradoxically strengthen the case for USAR as a national-security asset, accelerating Western supply chain independence. This policy backdrop supports long-term demand for domestic NdFeB magnets and could drive premium pricing for non-Chinese supply.
Bearish
- Catastrophic price collapse and falling knife: USAR is down 59.58% over the past year and 26.38% over the past month, trading at $12.56, just 9.7% above its 52-week low of $11.45. The 69.23% max drawdown and -75.58% relative strength versus SPY over one year confirm persistent distribution and no buyer support.
- Negative gross margin of -69.82%: Q2 2026 gross margin was -69.82% with gross profit of -$4.064 million, meaning USAR sells products below cost before operating expenses. The net margin of -181.11% and operating margin of -36.22% show costs vastly exceed revenue, and profitability depends on a scale inflection that has not yet materialized.
- Astronomical valuation on every metric: The trailing PS ratio of 709.95x and EV/Sales of 119.52x are thousands of percent above typical Basic Materials sector averages in the low single digits. Even the forward PE of 418.67x on estimated EPS of $2.145 prices in a complete business transformation that is far from assured.
- Massive dilution from $3.5B capital raise: Shares outstanding ballooned from 22.3 million in Q4 2024 to 196.5 million in Q2 2026, an 8.8x increase, with $1.5 billion in common stock issued in Q1 2026 alone. This extreme dilution transfers enormous value from existing shareholders and caps per-share upside even if the business succeeds.
USAR Technical Analysis
USA Rare Earth is in a sustained and severe downtrend, with the stock down 59.58% over the past year and trading at just 12.56, which places it at approximately 3.4% of its 52-week range (52-week low of 11.45, 52-week high of 43.98). This positioning near the absolute bottom of the annual range signals persistent distribution and a lack of buyer support rather than a value opportunity, and the 69.23% max drawdown underscores how punishing the decline has been for holders. The stock is effectively in a falling-knife configuration, sitting only about 9.7% above its 52-week low, meaning any further weakness risks a fresh breakdown to new lows. Recent momentum has been decisively negative and is accelerating to the downside: the stock is down 26.38% over the past month and 32.03% over three months, both far worse than the 1-year decline of 59.58% on a proportional basis, indicating the selloff has intensified rather than stabilized. This 1-month decline of 26.38% against a 1-year decline of 59.58% shows momentum is decelerating in the sense that the pace of losses remains steep, and the relative strength versus SPY is deeply negative at -28.50% over one month and -75.58% over one year, confirming severe underperformance. With a short ratio of 3.06 and volume of roughly 10.9 million shares, there is meaningful short interest that could fuel volatility in either direction, but the tape currently reflects sellers in control. Key technical support sits at the 52-week low of 11.45, roughly 8.8% below the current 12.56 price, and a breakdown below that level would likely trigger momentum-driven selling and open the door to price discovery to the downside. Resistance is layered far overhead, with the 52-week high of 43.98 representing a 250% gain from current levels and the recent September swing high near 17.00 acting as the first meaningful hurdle; reclaiming that level would be the first sign of stabilization. The beta of 2.684 is extraordinarily high, meaning the stock is roughly 168% more volatile than the market, so position sizing must be dramatically reduced relative to a typical equity and stop-losses should be wide enough to avoid noise-driven exits.
Beta
2.68
2.68x market volatility
Max Drawdown
-69.2%
Largest decline past year
52-Week Range
$11-$44
Price range past year
Annual Return
-59.6%
Cumulative gain past year
| Period | USAR Return | S&P 500 |
|---|---|---|
| 1m | -26.4% | +1.9% |
| 3m | -32.0% | +3.9% |
| 6m | -22.2% | +12.1% |
| 1y | -59.6% | +19.2% |
| ytd | -11.2% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
USAR Fundamental Analysis
USA Rare Earth's revenue trajectory is nascent and erratic, with Q2 2026 revenue of $5.821 million, up from $5.698 million in Q1 2026 and $1.643 million in Q4 2025, but the company reported zero revenue in the first three quarters of 2025, making year-over-year comparisons distorted. The sequential growth from Q4 2025 to Q2 2026 is encouraging at roughly 254% quarter-over-quarter, but the absolute base remains tiny relative to a market capitalization that has ranged from $1.17 billion to $5.28 billion, and the company derives maximum revenue internationally. This implies the investment case rests almost entirely on future production ramp and government-backed contracts rather than current commercial traction, and any execution delay would be severely punished given the valuation. Profitability remains deeply negative, with Q2 2026 net income of -$10.333 million, gross profit of -$4.064 million, and a gross margin of -69.82%, meaning the company sells its products at a negative gross margin before operating expenses. The net margin of -181.11% and operating margin of -36.22% confirm that costs vastly exceed revenue, and while the Q2 net loss of $10.3 million narrowed from Q1 2026's -$66.99 million and Q4 2025's -$50.21 million, the improvement was driven largely by non-operating items such as interest income and other income rather than core operations. The negative gross margin is a critical red flag, as it indicates the company's current processing and production economics do not yet support profitable operations, and margins will need to inflect positively as scale is achieved. The balance sheet is the company's strongest asset, with a current ratio of 10.17, a debt-to-equity ratio of just 0.0062, and cash of $1.594 billion at the end of Q2 2026, providing substantial runway. However, free cash flow is deeply negative at -$245.5 million on a trailing basis, with Q2 2026 free cash flow of -$126.6 million and capital expenditure of -$69.7 million, meaning the company is burning cash rapidly to build its facility. ROE of -60.40% and ROA of -4.45% reflect the poor returns on the large equity base raised through dilution, and the company is entirely dependent on external financing, having issued $1.5 billion in common stock in Q1 2026 alone, which is highly dilutive to existing shareholders.
Quarterly Revenue
$5821000.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
-69.8%
Latest Quarter
Free Cash Flow
$-245521000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is USAR Overvalued?
Because USA Rare Earth has negative net income (EPS of -$0.255 and trailing net income deeply negative), the PE ratio is not meaningful, and the appropriate primary metric is the price-to-sales ratio, which stands at an extraordinary 709.95x trailing. The forward PE of 418.67x is based on analyst estimated EPS of $2.145, implying the market expects a dramatic profitability inflection, but even that forward multiple is extreme and reflects speculative pricing rather than near-term fundamentals. The gap between the negative trailing PE of -3.60x and the positive forward PE of 418.67x implies the market is pricing in a complete transformation of the business from cash-burning to profitable, which is a very high bar. On a peer comparison basis, the PS ratio of 709.95x and EV/Sales of 119.52x are astronomically above typical Basic Materials sector averages, which generally range in the low single digits to low double digits, representing a premium of thousands of percent. This premium is not justified by current growth or profitability, as the company has a negative gross margin of -0.85% and a net margin of -181.11%, but it may be partially justified by the strategic national-security value of a domestic rare earth supply chain and the government-backed revenue guarantees. The PB ratio of 2.37x is more moderate and reflects the large cash raise, but it is still elevated for a pre-revenue industrial company. Historically, the stock's PS ratio has been extremely volatile, ranging from 0 in early periods when revenue was zero to 1,072x in Q4 2025 and 728x in Q2 2026, and the current 709.95x is near the high end of that historical band. This suggests the market is pricing in highly optimistic expectations for future revenue, and any disappointment in the Serra Verde acquisition, government contracts, or production ramp could lead to a severe multiple compression. The historical PE ratios are not meaningful due to negative earnings, but the PB ratio of 2.37x is below the Q4 2025 level of 3.58x and well below the 2024 levels above 8x, indicating the stock has already de-rated significantly from its peak enthusiasm.
PE
-3.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~28x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-14.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are severe and quantifiable. USAR generated Q2 2026 revenue of just $5.821 million against a gross margin of -69.82% and a net loss of $10.333 million, meaning the company loses money on every unit sold before operating expenses. Free cash flow is -$245.5 million TTM with Q2 2026 capex of -$69.7 million, and the company has funded this burn through massive dilution—shares outstanding rose from 22.3 million in Q4 2024 to 196.5 million in Q2 2026, an 8.8x increase. While the $1.594 billion cash balance and 10.17 current ratio provide runway, the company remains entirely dependent on external financing to complete the $1.2 billion South Carolina facility, and any delay in government contracts or the Serra Verde acquisition would accelerate cash depletion. The negative gross margin is the critical red flag: it indicates current processing economics do not support profitable operations, and margins must inflect positively as scale is achieved or the entire thesis collapses.
Market and competitive risks are equally pronounced. USAR trades at a PS ratio of 709.95x and EV/Sales of 119.52x, thousands of percent above typical Basic Materials sector averages in the low single digits, leaving enormous room for multiple compression if growth disappoints. The beta of 2.684 means the stock is roughly 168% more volatile than the market, so any macro risk-off rotation would hit USAR disproportionately hard—already evident in the -28.50% relative strength versus SPY over one month and -75.58% over one year. Competitive threats include China's export restrictions, which, while validating the strategic need, also disrupt supply chains and could delay USAR's own feedstock access, and the legal dispute with MP Materials, which adds litigation uncertainty. Recent news highlights a massive share overhang, China export restrictions, and the MP Materials dispute as drivers of the 23% June decline, and the analyst community has maintained Buy ratings without upgrades, suggesting limited near-term catalysts to reverse sentiment.
In a worst-case scenario, execution delays on the South Carolina facility or the Serra Verde acquisition combine with continued negative gross margins and a failure to secure additional government contracts, forcing another dilutive capital raise at depressed prices. This would likely drive the stock below its 52-week low of $11.45, opening the door to price discovery toward the $8–$10 range, representing a 20–36% loss from the current $12.56 price. The analyst low target of $21.00 would become irrelevant as the market prices in a broken growth story, and the 69.23% max drawdown already experienced shows how violently the stock can de-rate. In this adverse scenario, an investor could lose 35% or more from current levels, with the $11.45 support level serving as the first major downside marker and a break below it triggering momentum-driven selling.
FAQ
The most severe risk is financial: USAR has a -69.82% gross margin and -$245.5 million TTM free cash flow, meaning it loses money on every unit sold and burns cash rapidly, with Q2 2026 capex of -$69.7 million. Second is dilution risk: shares outstanding rose from 22.3 million in Q4 2024 to 196.5 million in Q2 2026, an 8.8x increase, and another large raise would further crush per-share value. Third is execution risk: the $1.2 billion South Carolina facility and the Serra Verde acquisition are both unproven, and any delay would push revenue out and increase cash burn. Fourth is competitive and macro risk: the beta of 2.684 makes USAR 168% more volatile than the market, and the MP Materials legal dispute plus China export restrictions add litigation and supply chain uncertainty. Ranked by severity, the financial and dilution risks are most immediate, followed by execution, then competitive and macro factors.
The 12-month forecast has three scenarios: a bull case with 25% probability targeting $35–$45, a base case with 50% probability targeting $18–$25, and a bear case with 25% probability targeting $8–$11.45. The base case is most likely, assuming gradual execution with some delays, revenue growing but staying well below the $3.007 billion analyst average, and gross margins improving slowly from -69.82% but staying negative through 2027. The key assumption behind the base case is that the $1.594 billion cash pile is sufficient to fund operations without another large equity raise, and that government contracts remain intact. The bull case requires the Serra Verde acquisition to close and gross margins to inflect positive, while the bear case is triggered by construction delays or a failed acquisition. The wide target range reflects very high uncertainty and low conviction in any single price outcome.
On traditional metrics, USAR is massively overvalued: the trailing PS ratio of 709.95x and EV/Sales of 119.52x are thousands of percent above typical Basic Materials sector averages in the low single digits. The forward PE of 418.67x on estimated EPS of $2.145 also prices in a complete transformation from cash-burning to profitable, which is a very high bar. However, the PB ratio of 2.37x is below the Q4 2025 level of 3.58x and well below 2024 levels above 8x, indicating the stock has already de-rated significantly from peak enthusiasm. The market is paying a premium for strategic national-security value and government-backed revenue guarantees, but that premium is not justified by current growth or profitability. Relative to its own history, the stock is cheaper on a book basis but still expensive on sales, so it is best described as fairly valued only if the transformation succeeds, and overvalued if execution stalls.
USAR is a high-risk, high-reward speculation rather than a conventional good buy. The analyst consensus is strong_buy with an average target of $35.56, implying 183% upside from $12.56, but the stock trades 64% below even the lowest target of $21.00, signaling a severe disconnect between analyst expectations and market pricing. The biggest downside risk is a break below the 52-week low of $11.45, which would represent a 9% loss from current levels and likely trigger momentum selling toward $8–$10. For risk-tolerant investors with a long time horizon and small position sizing, USAR offers genuine optionality on domestic rare earth supply chain independence, but the -69.82% gross margin and -$245.5 million TTM free cash flow mean it is not a good buy for conservative or income-oriented investors. It becomes a better buy if gross margins inflect positive or if the stock reclaims $17.00 on volume.
USAR is suitable only for long-term, risk-tolerant investors with a minimum holding period of 3–5 years, as the company is pre-revenue with a single reportable segment and 132 employees, and the investment case depends on multi-year execution of the South Carolina facility and Serra Verde acquisition. The beta of 2.684 and 69.23% max drawdown make it unsuitable for short-term trading unless using very small position sizes and wide stop-losses, as the stock is down 26.38% over the past month alone. USAR pays no dividend (payout ratio 0, dividend yield 0), so there is no income component to cushion volatility, and earnings visibility is extremely low given the erratic revenue history from zero in early 2025 to $5.821 million in Q2 2026. A long-term holder must be willing to tolerate 50%+ drawdowns and potential further dilution, and should size the position as a small speculative allocation rather than a core holding.